 |
 |
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
|
| Formulary Chapter 1: Gastro-intestinal system - Full Section
|
Notes:
Gastroenterology-related Prescribing Guidance
Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.
Gastroenterology-related Shared Care Agreements
Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter.
Self-care
Many of the products in this chapter are available for purchase over-the-counter, and patients are encouraged to self-care, with the support of their community pharmacist, in the first instance.
For further information on self-care & the NHS, please refer to
https://www.england.nhs.uk/publication/conditions-for-which-over-the-counter-items-should-not-routinely-be-prescribed-in-primary-care-guidance-for-ccgs/ |
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
01.01 |
Dyspepsia and gastro-oesophageal reflux disease
(0,1)
|
|
01.01.01 |
Antacids and simeticone
(0,1)
|
|
|
Aluminium and magnesium containing antacids
(2,5)
|
|
|
Antacid preparations containing simeticone
(1,2)
|
|
|
Simeticine alone
(2,1)
|
|
01.01.02 |
Compound alginates and proprietary indigestion preparations
(0,0)
|
|
|
Compound alginate preparations
(3,6)
|
|
01.02 |
Antispasmodics and other drugs altering gut motility
(0,0)
|
|
|
Antimuscarinics
(2,2)
|
|
|
Other antispasmodics
(3,4)
|
|
|
Motility stimulants
(2,0)
|
|
01.03 |
Antisecretory drugs and mucosal protectants
(0,0)
|
|
|
Helicobacter pylori infection
(0,4)
|
|
01.03.01 |
H2-receptor antagonists
(2,8)
|
|
01.03.03 |
Chelates and complexes
(2,1)
|
|
01.03.04 |
Prostaglandin analogues
(0,1)
|
|
01.03.05 |
Proton pump inhibitors (PPIs)
(5,7)
|
|
01.04 |
Acute diarrhoea
(0,0)
|
|
01.04.01 |
Adsorbents and bulk-forming drugs
(0,1)
|
|
01.04.02 |
Antimotility drugs
(2,5)
|
|
01.04.03 |
Enkephalinase Inhibitors
(0,1)
|
|
01.05 |
Chronic bowel disorders
(0,0)
|
|
01.05.01 |
Aminosalicylates
(4,3)
|
|
01.05.02 |
Corticosteroids
(0,2)
|
|
|
Oral
(4,0)
|
|
|
Topical
(3,0)
|
|
01.05.03 |
Drugs affecting the immune response
(10,0)
|
|
01.05.04 |
Food allergy
(0,1)
|
|
01.06 |
Laxatives
(0,0)
|
|
01.06.01 |
Bulk-forming laxatives
(3,1)
|
|
01.06.02 |
Stimulant laxatives
(4,5)
|
|
01.06.03 |
Faecal softeners
(1,1)
|
|
01.06.04 |
Osmotic laxatives
(5,0)
|
|
01.06.05 |
Bowel cleansing preparations
(6,6)
|
|
01.06.06 |
Peripheral opioid-receptor antagonist
(1,0)
|
|
01.06.07 |
Other drugs used in constipation
(2,1)
|
|
01.07 |
Local preparations for anal and rectal disorders
(0,0)
|
|
01.07.01 |
Soothing haemorrhoidal preparations
(1,3)
|
|
01.07.02 |
Compound haemorrhoidal preparations with corticosteroids
(2,7)
|
|
01.07.03 |
Rectal sclerosants
(1,0)
|
|
01.07.04 |
Management of anal fissures
(2,1)
|
|
01.08 |
Stoma care
(0,0)
|
|
01.09 |
Drugs affecting intestinal secretions
(0,0)
|
|
01.09.01 |
Drugs affecting biliary composition and flow
(2,3)
|
|
01.09.02 |
Bile acid sequestrants
(3,0)
|
|
01.09.03 |
Aprotinin
(0,0)
|
|
01.09.04 |
Pancreatin
(1,4)
|
|
|
|
